References
- Hvas L. Positive aspects of menopause: a qualitative study. Maturitas 2001;39(1):11-17
- Ayers B, Hunter MS. Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 2013;16(2):253-9
- Van Dole KB, Williams RE, Brown RS, et al. Longitudinal association of vasomotor symptoms and psychosocial outcomes among postmenopausal women in the United States: a population-based study. Menopause 2010;17(5):917-23
- Reed SD, Ludman EJ, Newton KM, et al. Depressive symptoms and menopausal burden in the midlife. Maturitas 2009;62(3):306-10
- Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9(6):392-8
- Umland EM. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag Care Pharm 2008;14(3 Suppl):14-19
- Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen and plus progestin on health-related quality of life. N Engl J Med 2003;348(19):1839-54
- Utian WH, Janata JW, Kingsberg SA, et al. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause 2002;9(6):402-10
- Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic sample of middle-aged women: Study of Women’s Health Across the Nation. Menopause 2009;16(5):860-9
- Whiteley J, DiBonaventura MD, Wagner JS, et al. The impact of menopausal symptoms on life, productivity, and economic outcomes. J Womens Health 2013;22(11):983-90
- Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997;3(2):103-20
- Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2005;3:47-54
- Nachtigall LE, Nachtigakk MJ. Menopausal changes, quality of life, and hormone therapy. Clin Obstet Gynecol 2004;47(2):485-8
- North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11(1):11-33
- Feldman BM, Voda A, Gronseth E. The prevalence of hot flush and associated variables among perimenopausal women. Res Nurs Health 1985;8(3):261-8
- Williams RE, Kalilani L, DiBenedetti DB, et al. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007;58:348-58
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen and plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33
- Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53
- Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in post-menopause hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol 2012;120(3):595-603
- Hillman JJ, Zuckerman IH, Lee E. The impact of women’s health initiative on hormone replacement therapy in a Medicaid program. J Womens Health 2004;13(9):986-92
- Ettinger B, Wang SM, Leslie RS, et al. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 2012;19(6):610-15
- Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause 2015;22(3):260-6
- Kleinman NL, Rohrbacker NJ, Bushmakin AG, et al. Direct and indirect costs of women diagnosed with menopause symptoms. J Occup Environ Med 2013;55(4):465-70
- DiBonaventura MD, Chandran A, Hsu MA, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health 2013;5:261-9
- Viliet EL. Menopause and perimenopause: the role of ovarian hormones in common neuroendocrine syndromes in primary care. Prim Care 2002;29:43-67
- Sasser AC, Rousculp MD, Birnbaum HG, et al. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues 2005;15(3):97-108
- Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61(12):1234-40
- Szmuilowicz ED, Manson JE, Rossouw JE, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause 2011;18(6):603-10
- Thurston RC, Sutton-Tyrrell K, Powell L, et al. Hot flashes and carotid intima media thickness: findings from the SWAN heart study [abstract] Menopause. 2009;16:1237
- Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16(2):239-46
- Hakim RB, Benedict B, Merrick NJ. Quality of care for women undergoing a hysterectomy: effects of insurance and race/ethnicity. Am J Public Health 2004;94(8):1399-405
- Hess R, Chang CC, Ness RB, et al. The associations of menopause and health-related quality of life with health services utilization. Results from the STRIDE project. Abstract presented at the 32nd Annual Meeting of the Society of Medical Decision Making; 24–27 October 2010. Toronto, Ontario, Canada
- Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342(25):1878-86
- Riley GF. Administrative and claims records as sources of healthcare cost data. Med Care 2009;7(S1):S51-5